This is likely due to the fact that once the weight loss medication is stopped, patients do not feel satiated as quickly, frequent hunger returns, and previous food cravings come back
Potentially effective drugs for the treatment of COVID-19 or MIS-C in children: a systematic review
Bioavailability is the term we use to describe the portion of a substance that enters the circulation when introduced into the body and is so able to have an active effect
[9] Broader pharmacovigilance databases list rare but potentially serious events: rash, oedema, transient hypotension, hematuria, airway hyper-reactivity, and syncope
However, some users report new or worsening gut symptoms such as nausea, vomiting and slowed digestion after starting treatment